Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression
العنوان: | Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression |
---|---|
المؤلفون: | Jan A. Åkervall, Rob Michalides, Hiroyuki Mineta, Åke Borg, Alfons Balm, Johan P. Wennerberg, Barbara Loftus, Yuesheng Jin, Fredrik Mertens, Michael R. Dictor |
المساهمون: | Other departments |
المصدر: | Cancer, 79(2), 380-389. John Wiley and Sons Inc. |
بيانات النشر: | Wiley, 1997. |
سنة النشر: | 1997 |
مصطلحات موضوعية: | Adult, Male, Cancer Research, medicine.medical_specialty, Cyclin D, Cyclin B, medicine.disease_cause, Cyclin D1, Cyclins, medicine, Humans, Aged, Aged, 80 and over, Chromosome Aberrations, Gene Rearrangement, Oncogene Proteins, biology, Chromosomes, Human, Pair 11, Gene Amplification, Cytogenetics, Cancer, Gene rearrangement, Middle Aged, Prognosis, medicine.disease, Neoplasm Proteins, Phenotype, Oncology, Epidermoid carcinoma, Head and Neck Neoplasms, Carcinoma, Squamous Cell, Cancer research, biology.protein, Female, Carcinogenesis |
الوصف: | BACKGROUND Abnormalities of chromosome band 11q13 are frequent in squamous cell carcinoma of the head and neck (SCCHN). The oncogene CCND1 is located at 11q13 and encodes cyclin D1, a cell cycle-regulating protein. The authors investigated the clinical relevance and associations between amplification and overexpression of cyclin D1 and 11q13 rearrangements. METHODS The study involved two series of patients. In Series 1, overexpression of cyclin D1 and 11q13 rearrangements, assessed by immunohistochemistry and cytogenetics, respectively, were compared with clinical data in 75 patients with SCCHN. Patients were monitored for at least 18 months or until death. In another 23 patients (Series 2), the authors investigated the association between DNA amplification (by slot blot hybridization), overexpression of cyclin D1, and cytogenetics. RESULTS In Series 1, 9 of 75 tumors (12%) had 11q13 aberrations, 6 of which manifested elevated expression of cyclin D1. Patients with tumors strongly positive for cyclin D1 (n = 9) and those with tumors showing 11q13 rearrangements had poorer survival (P = 0.047 and 0.005, respectively). However, the correlation between these two variables was weak (P = 0.12). In Series 2, 17 of 23 tumors (74%) showed elevated cyclin D1 protein expression, and 6 of these showed gene amplification as well. Of these six, only one revealed 11q13 rearrangements. CONCLUSIONS Overexpression of cyclin D1 and 11q13 rearrangements are independent prognostic factors for SCCHN. In general, DNA amplification results in overexpression of cyclin D1, but additional genetic mechanisms are involved in the deregulation. Furthermore, oncogenes at 11q13 besides CCND1 may be involved in the tumorigenesis. Cancer 1997; 79:380-9. © 1997 American Cancer Society. |
تدمد: | 1097-0142 0008-543X |
DOI: | 10.1002/(sici)1097-0142(19970115)79:2<380::aid-cncr22>3.0.co;2-w |
URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f9d374710051a338ea6832193d975bf https://doi.org/10.1002/(sici)1097-0142(19970115)79:2<380::aid-cncr22>3.0.co;2-w |
Rights: | RESTRICTED |
رقم الانضمام: | edsair.doi.dedup.....2f9d374710051a338ea6832193d975bf |
قاعدة البيانات: | OpenAIRE |
ResultId |
1 |
---|---|
Header |
edsair OpenAIRE edsair.doi.dedup.....2f9d374710051a338ea6832193d975bf 774 3 unknown 774.46142578125 |
PLink |
https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....2f9d374710051a338ea6832193d975bf&custid=s6537998&authtype=sso |
FullText |
Array
(
[Availability] => 0
)
Array ( [0] => Array ( [Url] => https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f9d374710051a338ea6832193d975bf# [Name] => EDS - OpenAIRE [Category] => fullText [Text] => View record in OpenAIRE [MouseOverText] => View record in OpenAIRE ) ) |
Items |
Array
(
[Name] => Title
[Label] => Title
[Group] => Ti
[Data] => Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression
)
Array ( [Name] => Author [Label] => Authors [Group] => Au [Data] => <searchLink fieldCode="AR" term="%22Jan+A%2E+Åkervall%22">Jan A. Åkervall</searchLink><br /><searchLink fieldCode="AR" term="%22Rob+Michalides%22">Rob Michalides</searchLink><br /><searchLink fieldCode="AR" term="%22Hiroyuki+Mineta%22">Hiroyuki Mineta</searchLink><br /><searchLink fieldCode="AR" term="%22Åke+Borg%22">Åke Borg</searchLink><br /><searchLink fieldCode="AR" term="%22Alfons+Balm%22">Alfons Balm</searchLink><br /><searchLink fieldCode="AR" term="%22Johan+P%2E+Wennerberg%22">Johan P. Wennerberg</searchLink><br /><searchLink fieldCode="AR" term="%22Barbara+Loftus%22">Barbara Loftus</searchLink><br /><searchLink fieldCode="AR" term="%22Yuesheng+Jin%22">Yuesheng Jin</searchLink><br /><searchLink fieldCode="AR" term="%22Fredrik+Mertens%22">Fredrik Mertens</searchLink><br /><searchLink fieldCode="AR" term="%22Michael+R%2E+Dictor%22">Michael R. Dictor</searchLink> ) Array ( [Name] => Author [Label] => Contributors [Group] => Au [Data] => Other departments ) Array ( [Name] => TitleSource [Label] => Source [Group] => Src [Data] => Cancer, 79(2), 380-389. John Wiley and Sons Inc. ) Array ( [Name] => Publisher [Label] => Publisher Information [Group] => PubInfo [Data] => Wiley, 1997. ) Array ( [Name] => DatePubCY [Label] => Publication Year [Group] => Date [Data] => 1997 ) Array ( [Name] => Subject [Label] => Subject Terms [Group] => Su [Data] => <searchLink fieldCode="DE" term="%22Adult%22">Adult</searchLink><br /><searchLink fieldCode="DE" term="%22Male%22">Male</searchLink><br /><searchLink fieldCode="DE" term="%22Cancer+Research%22">Cancer Research</searchLink><br /><searchLink fieldCode="DE" term="%22medicine%2Emedical%5Fspecialty%22">medicine.medical_specialty</searchLink><br /><searchLink fieldCode="DE" term="%22Cyclin+D%22">Cyclin D</searchLink><br /><searchLink fieldCode="DE" term="%22Cyclin+B%22">Cyclin B</searchLink><br /><searchLink fieldCode="DE" term="%22medicine%2Edisease%5Fcause%22">medicine.disease_cause</searchLink><br /><searchLink fieldCode="DE" term="%22Cyclin+D1%22">Cyclin D1</searchLink><br /><searchLink fieldCode="DE" term="%22Cyclins%22">Cyclins</searchLink><br /><searchLink fieldCode="DE" term="%22medicine%22">medicine</searchLink><br /><searchLink fieldCode="DE" term="%22Humans%22">Humans</searchLink><br /><searchLink fieldCode="DE" term="%22Aged%22">Aged</searchLink><br /><searchLink fieldCode="DE" term="%22Aged%2C+80+and+over%22">Aged, 80 and over</searchLink><br /><searchLink fieldCode="DE" term="%22Chromosome+Aberrations%22">Chromosome Aberrations</searchLink><br /><searchLink fieldCode="DE" term="%22Gene+Rearrangement%22">Gene Rearrangement</searchLink><br /><searchLink fieldCode="DE" term="%22Oncogene+Proteins%22">Oncogene Proteins</searchLink><br /><searchLink fieldCode="DE" term="%22biology%22">biology</searchLink><br /><searchLink fieldCode="DE" term="%22Chromosomes%2C+Human%2C+Pair+11%22">Chromosomes, Human, Pair 11</searchLink><br /><searchLink fieldCode="DE" term="%22Gene+Amplification%22">Gene Amplification</searchLink><br /><searchLink fieldCode="DE" term="%22Cytogenetics%22">Cytogenetics</searchLink><br /><searchLink fieldCode="DE" term="%22Cancer%22">Cancer</searchLink><br /><searchLink fieldCode="DE" term="%22Gene+rearrangement%22">Gene rearrangement</searchLink><br /><searchLink fieldCode="DE" term="%22Middle+Aged%22">Middle Aged</searchLink><br /><searchLink fieldCode="DE" term="%22Prognosis%22">Prognosis</searchLink><br /><searchLink fieldCode="DE" term="%22medicine%2Edisease%22">medicine.disease</searchLink><br /><searchLink fieldCode="DE" term="%22Neoplasm+Proteins%22">Neoplasm Proteins</searchLink><br /><searchLink fieldCode="DE" term="%22Phenotype%22">Phenotype</searchLink><br /><searchLink fieldCode="DE" term="%22Oncology%22">Oncology</searchLink><br /><searchLink fieldCode="DE" term="%22Epidermoid+carcinoma%22">Epidermoid carcinoma</searchLink><br /><searchLink fieldCode="DE" term="%22Head+and+Neck+Neoplasms%22">Head and Neck Neoplasms</searchLink><br /><searchLink fieldCode="DE" term="%22Carcinoma%2C+Squamous+Cell%22">Carcinoma, Squamous Cell</searchLink><br /><searchLink fieldCode="DE" term="%22Cancer+research%22">Cancer research</searchLink><br /><searchLink fieldCode="DE" term="%22biology%2Eprotein%22">biology.protein</searchLink><br /><searchLink fieldCode="DE" term="%22Female%22">Female</searchLink><br /><searchLink fieldCode="DE" term="%22Carcinogenesis%22">Carcinogenesis</searchLink> ) Array ( [Name] => Abstract [Label] => Description [Group] => Ab [Data] => BACKGROUND Abnormalities of chromosome band 11q13 are frequent in squamous cell carcinoma of the head and neck (SCCHN). The oncogene CCND1 is located at 11q13 and encodes cyclin D1, a cell cycle-regulating protein. The authors investigated the clinical relevance and associations between amplification and overexpression of cyclin D1 and 11q13 rearrangements. METHODS The study involved two series of patients. In Series 1, overexpression of cyclin D1 and 11q13 rearrangements, assessed by immunohistochemistry and cytogenetics, respectively, were compared with clinical data in 75 patients with SCCHN. Patients were monitored for at least 18 months or until death. In another 23 patients (Series 2), the authors investigated the association between DNA amplification (by slot blot hybridization), overexpression of cyclin D1, and cytogenetics. RESULTS In Series 1, 9 of 75 tumors (12%) had 11q13 aberrations, 6 of which manifested elevated expression of cyclin D1. Patients with tumors strongly positive for cyclin D1 (n = 9) and those with tumors showing 11q13 rearrangements had poorer survival (P = 0.047 and 0.005, respectively). However, the correlation between these two variables was weak (P = 0.12). In Series 2, 17 of 23 tumors (74%) showed elevated cyclin D1 protein expression, and 6 of these showed gene amplification as well. Of these six, only one revealed 11q13 rearrangements. CONCLUSIONS Overexpression of cyclin D1 and 11q13 rearrangements are independent prognostic factors for SCCHN. In general, DNA amplification results in overexpression of cyclin D1, but additional genetic mechanisms are involved in the deregulation. Furthermore, oncogenes at 11q13 besides CCND1 may be involved in the tumorigenesis. Cancer 1997; 79:380-9. © 1997 American Cancer Society. ) Array ( [Name] => ISSN [Label] => ISSN [Group] => ISSN [Data] => 1097-0142<br />0008-543X ) Array ( [Name] => DOI [Label] => DOI [Group] => ID [Data] => 10.1002/(sici)1097-0142(19970115)79:2<380::aid-cncr22>3.0.co;2-w ) Array ( [Name] => URL [Label] => Access URL [Group] => URL [Data] => <link linkTarget="URL" linkTerm="https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f9d374710051a338ea6832193d975bf" linkWindow="_blank">https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f9d374710051a338ea6832193d975bf</link><br /><link linkTarget="URL" linkTerm="https://doi.org/10.1002/(sici)1097-0142(19970115)79:2<380::aid-cncr22>3.0.co;2-w" linkWindow="_blank">https://doi.org/10.1002/(sici)1097-0142(19970115)79:2<380::aid-cncr22>3.0.co;2-w</link> ) Array ( [Name] => Copyright [Label] => Rights [Group] => Cpyrght [Data] => RESTRICTED ) Array ( [Name] => AN [Label] => Accession Number [Group] => ID [Data] => edsair.doi.dedup.....2f9d374710051a338ea6832193d975bf ) |
RecordInfo |
Array
(
[BibEntity] => Array
(
[Identifiers] => Array
(
[0] => Array
(
[Type] => doi
[Value] => 10.1002/(sici)1097-0142(19970115)79:2<380::aid-cncr22>3.0.co;2-w
)
)
[Languages] => Array
(
[0] => Array
(
[Text] => Undetermined
)
)
[PhysicalDescription] => Array
(
[Pagination] => Array
(
[PageCount] => 10
[StartPage] => 380
)
)
[Subjects] => Array
(
[0] => Array
(
[SubjectFull] => Adult
[Type] => general
)
[1] => Array
(
[SubjectFull] => Male
[Type] => general
)
[2] => Array
(
[SubjectFull] => Cancer Research
[Type] => general
)
[3] => Array
(
[SubjectFull] => medicine.medical_specialty
[Type] => general
)
[4] => Array
(
[SubjectFull] => Cyclin D
[Type] => general
)
[5] => Array
(
[SubjectFull] => Cyclin B
[Type] => general
)
[6] => Array
(
[SubjectFull] => medicine.disease_cause
[Type] => general
)
[7] => Array
(
[SubjectFull] => Cyclin D1
[Type] => general
)
[8] => Array
(
[SubjectFull] => Cyclins
[Type] => general
)
[9] => Array
(
[SubjectFull] => medicine
[Type] => general
)
[10] => Array
(
[SubjectFull] => Humans
[Type] => general
)
[11] => Array
(
[SubjectFull] => Aged
[Type] => general
)
[12] => Array
(
[SubjectFull] => Aged, 80 and over
[Type] => general
)
[13] => Array
(
[SubjectFull] => Chromosome Aberrations
[Type] => general
)
[14] => Array
(
[SubjectFull] => Gene Rearrangement
[Type] => general
)
[15] => Array
(
[SubjectFull] => Oncogene Proteins
[Type] => general
)
[16] => Array
(
[SubjectFull] => biology
[Type] => general
)
[17] => Array
(
[SubjectFull] => Chromosomes, Human, Pair 11
[Type] => general
)
[18] => Array
(
[SubjectFull] => Gene Amplification
[Type] => general
)
[19] => Array
(
[SubjectFull] => Cytogenetics
[Type] => general
)
[20] => Array
(
[SubjectFull] => Cancer
[Type] => general
)
[21] => Array
(
[SubjectFull] => Gene rearrangement
[Type] => general
)
[22] => Array
(
[SubjectFull] => Middle Aged
[Type] => general
)
[23] => Array
(
[SubjectFull] => Prognosis
[Type] => general
)
[24] => Array
(
[SubjectFull] => medicine.disease
[Type] => general
)
[25] => Array
(
[SubjectFull] => Neoplasm Proteins
[Type] => general
)
[26] => Array
(
[SubjectFull] => Phenotype
[Type] => general
)
[27] => Array
(
[SubjectFull] => Oncology
[Type] => general
)
[28] => Array
(
[SubjectFull] => Epidermoid carcinoma
[Type] => general
)
[29] => Array
(
[SubjectFull] => Head and Neck Neoplasms
[Type] => general
)
[30] => Array
(
[SubjectFull] => Carcinoma, Squamous Cell
[Type] => general
)
[31] => Array
(
[SubjectFull] => Cancer research
[Type] => general
)
[32] => Array
(
[SubjectFull] => biology.protein
[Type] => general
)
[33] => Array
(
[SubjectFull] => Female
[Type] => general
)
[34] => Array
(
[SubjectFull] => Carcinogenesis
[Type] => general
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression
[Type] => main
)
)
)
[BibRelationships] => Array
(
[HasContributorRelationships] => Array
(
[0] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Jan A. Åkervall
)
)
)
[1] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Rob Michalides
)
)
)
[2] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Hiroyuki Mineta
)
)
)
[3] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Åke Borg
)
)
)
[4] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Alfons Balm
)
)
)
[5] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Johan P. Wennerberg
)
)
)
[6] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Barbara Loftus
)
)
)
[7] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Yuesheng Jin
)
)
)
[8] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Fredrik Mertens
)
)
)
[9] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Michael R. Dictor
)
)
)
[10] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Other departments
)
)
)
)
[IsPartOfRelationships] => Array
(
[0] => Array
(
[BibEntity] => Array
(
[Dates] => Array
(
[0] => Array
(
[D] => 15
[M] => 01
[Type] => published
[Y] => 1997
)
)
[Identifiers] => Array
(
[0] => Array
(
[Type] => issn-print
[Value] => 10970142
)
[1] => Array
(
[Type] => issn-print
[Value] => 0008543X
)
[2] => Array
(
[Type] => issn-locals
[Value] => edsair
)
)
[Numbering] => Array
(
[0] => Array
(
[Type] => volume
[Value] => 79
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => Cancer
[Type] => main
)
)
)
)
)
)
)
|
IllustrationInfo |